ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,424, issued on May 19, was assigned to Northwestern University (Evanston, Ill.).
"Targeting Pleckstrin-2 for treating cancer" was invented by Peng Ji (Wilmette, Ill.), Gary E. Schiltz (Naperville, Ill.), Rama K. Mishra (Chicago) and Atul D. Jain (Chicago).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds, compositions, and methods for treating cell proliferative diseases and disorders based on present inventors discovery that Pleckstrin-2 (Plek2) can be targeted to treat cell proliferative diseases and disorders. The compositions and methods disclosed herein include or utilize the disclosed compounds as therapeutic agents w...